• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苏里南结核病与艾滋病毒合并感染者的死亡相关因素:一项回顾性队列研究

Factors associated with mortality in persons co-infected with tuberculosis and HIV in Suriname: a retrospective cohort study.

作者信息

Stijnberg Deborah, Commiesie Eric, Marín Diana, Schrooten Ward, Perez Freddy, Sanchez Mauro

机构信息

Ministry of Health Ministry of Health Paramaribo Suriname Ministry of Health, Paramaribo, Suriname.

National Tuberculosis Program National Tuberculosis Program Paramaribo Suriname National Tuberculosis Program, Paramaribo, Suriname.

出版信息

Rev Panam Salud Publica. 2019 Dec 20;43:e103. doi: 10.26633/RPSP.2019.103. eCollection 2019.

DOI:10.26633/RPSP.2019.103
PMID:31892929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6922075/
Abstract

OBJECTIVE

To identify socio-demographic and clinical factors associated with mortality among persons with tuberculosis (TB) and TB/HIV co-infection in Suriname.

METHODS

This was a retrospective cohort study using data from the national TB and HIV databases for 2010 - 2015. The survival probability of TB and TB/HIV co-infected patients was analyzed using the Kaplan-Meier estimates and the log-rank test. A Cox proportional hazard model was applied.

RESULTS

The study showed that HIV-seropositivity (aHR: 2.08, 95%CI: 1.48 - 2.92) and older age (aHR: 5.84, 95%CI: 3.00 - 11.4) are statistically associated with higher mortality. For the TB/HIV co-infected patients, TB treatment (aHR: 0.43, 95%CI: 0.35 - 0.53) reduces the risk of death. Similarly, HIV treatment started within 56 days (aHR: 0.15, 95%CI: 0.12 - 0.19) and delayed (aHR: 0.25, 95%CI: 0.13 - 0.47) result in less hazard for mortality; Directly-Observed Treatment (aOR: 0.16, 95%CI: 0.09 - 0.29) further reduces the risk.

CONCLUSIONS

The Ministry of Health of Suriname should develop strategies for early case-finding in key populations, such as for HIV and TB in men 60 years of age and older. Implementation of Isoniazid Preventive Therapy for HIV should be pursued. Scaling up TB and HIV treatment, preferably through supervision, are essential to reducing the TB/HIV mortality.

摘要

目的

确定苏里南结核病(TB)患者及TB/HIV合并感染患者中与死亡率相关的社会人口学和临床因素。

方法

这是一项回顾性队列研究,使用了2010 - 2015年国家结核病和艾滋病毒数据库的数据。采用Kaplan-Meier估计法和对数秩检验分析TB及TB/HIV合并感染患者的生存概率。应用Cox比例风险模型。

结果

研究表明,HIV血清阳性(调整后风险比:2.08,95%置信区间:1.48 - 2.92)和高龄(调整后风险比:5.84,95%置信区间:3.00 - 11.4)在统计学上与较高死亡率相关。对于TB/HIV合并感染患者,结核病治疗(调整后风险比:0.43,95%置信区间:0.35 - 0.53)可降低死亡风险。同样,在56天内开始抗艾滋病毒治疗(调整后风险比:0.15,95%置信区间:0.12 - 0.19)和延迟治疗(调整后风险比:0.25,95%置信区间:0.13 - 0.47)可降低死亡风险;直接观察治疗(调整后比值比:0.16,95%置信区间:0.09 - 0.29)可进一步降低风险。

结论

苏里南卫生部应制定针对重点人群的早期病例发现策略,如60岁及以上男性中的艾滋病毒和结核病患者。应推行对艾滋病毒感染者的异烟肼预防性治疗。扩大结核病和艾滋病毒治疗规模,最好通过监督进行,对于降低TB/HIV死亡率至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/6922075/50cf6048bf15/rpsp-43-e103_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/6922075/50cf6048bf15/rpsp-43-e103_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/6922075/50cf6048bf15/rpsp-43-e103_Figure1.jpg

相似文献

1
Factors associated with mortality in persons co-infected with tuberculosis and HIV in Suriname: a retrospective cohort study.苏里南结核病与艾滋病毒合并感染者的死亡相关因素:一项回顾性队列研究
Rev Panam Salud Publica. 2019 Dec 20;43:e103. doi: 10.26633/RPSP.2019.103. eCollection 2019.
2
The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.埃塞俄比亚吉马地区接受抗逆转录病毒治疗前护理的艾滋病毒感染者中,异烟肼预防性治疗对结核病发病率的影响:一项回顾性队列研究。
BMC Public Health. 2015 Apr 10;15:346. doi: 10.1186/s12889-015-1719-0.
3
Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.预测在埃塞俄比亚西北部接受结核病治疗的结核-艾滋病毒合并感染患者的死亡率:一项回顾性队列研究。
BMC Infect Dis. 2013 Jul 1;13:297. doi: 10.1186/1471-2334-13-297.
4
Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.坦桑尼亚 HIV 感染成人中异烟肼预防治疗对结核病发病率及相关危险因素的影响:一项回顾性队列研究。
BMC Infect Dis. 2019 Jan 17;19(1):62. doi: 10.1186/s12879-019-3696-x.
5
Factors associated with time to death among HIV/TB co-infected patients on ART in Dire Dawa, Ethiopia: A retrospective study.埃塞俄比亚迪雷达瓦接受抗逆转录病毒治疗的艾滋病毒/结核病合并感染患者的死亡时间相关因素:一项回顾性研究。
Heliyon. 2024 Sep 5;10(17):e37420. doi: 10.1016/j.heliyon.2024.e37420. eCollection 2024 Sep 15.
6
[Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry].[科纳克里埃博拉疫情期间合并感染艾滋病毒的新结核病患者的治疗结果、生存率及其危险因素]
Rev Epidemiol Sante Publique. 2017 Nov;65(6):419-426. doi: 10.1016/j.respe.2017.05.011. Epub 2017 Oct 22.
7
Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.在埃塞俄比亚西北部贡德尔大学综合专科医院,感染结核分枝杆菌和人类免疫缺陷病毒的儿童的生存和死亡预测因素。一项回顾性随访研究。
PLoS One. 2018 May 22;13(5):e0197145. doi: 10.1371/journal.pone.0197145. eCollection 2018.
8
Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.2009-2016 年埃塞俄比亚梅克尔两家政府医院成人结核病/艾滋病双重感染患者脱失的发生率及其预测因素:生存模型方法。
BMC Infect Dis. 2019 Feb 4;19(1):107. doi: 10.1186/s12879-019-3756-2.
9
Predictors of mortality among TB-HIV co-infected children attending anti-retroviral therapy clinics of selected public hospitals in southern, Ethiopia: retrospective cohort study.埃塞俄比亚南部部分公立医院抗逆转录病毒治疗诊所中合并感染结核病和艾滋病病毒儿童的死亡率预测因素:回顾性队列研究
Arch Public Health. 2022 Jan 4;80(1):11. doi: 10.1186/s13690-021-00713-1.
10
Epidemiology of Pediatric Tuberculosis in Kenya and Risk Factors for Mortality during Treatment: A National Retrospective Cohort Study.肯尼亚儿科结核病的流行病学和治疗期间死亡的危险因素:一项全国回顾性队列研究。
J Pediatr. 2018 Oct;201:115-121. doi: 10.1016/j.jpeds.2018.05.017. Epub 2018 Jun 6.

引用本文的文献

1
Age-specific relationship between HIV and TB treatment outcomes in the West Region of Cameroon: a cross-sectional study.喀麦隆西部地区艾滋病毒与结核病治疗结果的年龄特异性关系:一项横断面研究。
BMC Infect Dis. 2025 Apr 7;25(1):475. doi: 10.1186/s12879-025-10860-3.
2
Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality.苏里南结核病流行的主要驱动因素以及降低发病率和死亡率的优先行动。
IJTLD Open. 2024 Jan 1;1(1):34-40. doi: 10.5588/ijtldopen.23.0535. eCollection 2024 Jan.
3
Survival and predictors of death in tuberculosis/HIV coinfection cases in Porto Alegre, Brazil: A historical cohort from 2009 to 2013.

本文引用的文献

1
High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.尼日利亚接受治疗的结核病患者死亡率高:一项回顾性队列研究。
BMC Infect Dis. 2017 Feb 23;17(1):170. doi: 10.1186/s12879-017-2249-4.
2
Determinants of tuberculosis in countries of Latin America and the Caribbean.拉丁美洲和加勒比地区各国结核病的决定因素。
Rev Panam Salud Publica. 2016 Feb;39(2):101-105.
3
Integrated therapy for HIV and tuberculosis.艾滋病病毒与结核病的综合治疗
巴西阿雷格里港结核病/艾滋病病毒合并感染病例的生存情况及死亡预测因素:一项2009年至2013年的历史性队列研究
PLOS Glob Public Health. 2021 Nov 10;1(11):e0000051. doi: 10.1371/journal.pgph.0000051. eCollection 2021.
4
Low transcriptomic of PTPRCv1 and CD3E is an independent predictor of mortality in HIV and tuberculosis co-infected patient.PTPRCv1 和 CD3E 的低转录组是 HIV 和结核分枝杆菌合并感染患者死亡的独立预测因子。
Sci Rep. 2022 Jun 16;12(1):10133. doi: 10.1038/s41598-022-14305-8.
5
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?低水平利福平单耐药结核病的治疗是否应该有所不同?
J Clin Tuberc Other Mycobact Dis. 2021 Jan 29;23:100222. doi: 10.1016/j.jctube.2021.100222. eCollection 2021 May.
AIDS Res Ther. 2016 May 12;13:22. doi: 10.1186/s12981-016-0106-y. eCollection 2016.
4
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.结核病相关死亡率在欧洲和拉丁美洲的艾滋病毒感染者中:一项国际队列研究。
Lancet HIV. 2016 Mar;3(3):e120-31. doi: 10.1016/S2352-3018(15)00252-0. Epub 2016 Feb 2.
5
Clearing the smoke around the TB-HIV syndemic: smoking as a critical issue for TB and HIV treatment and care.拨开结核病与艾滋病并发流行的迷雾:吸烟是结核病和艾滋病治疗与照护中的关键问题
Int J Tuberc Lung Dis. 2015 Sep;19(9):1003-6. doi: 10.5588/ijtld.14.0813.
6
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.在非洲开展的早期抗逆转录病毒治疗和异烟肼预防治疗试验。
N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.
7
Tuberculosis is associated with non-tuberculosis-related deaths among HIV/AIDS patients in Rio de Janeiro.在里约热内卢,结核病与艾滋病毒/艾滋病患者的非结核病相关死亡有关。
Int J Tuberc Lung Dis. 2014 Dec;18(12):1473-8. doi: 10.5588/ijtld.14.0181.
8
The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.抗逆转录病毒疗法对HIV阳性患者结核病治疗期间死亡率的影响:一项系统评价和荟萃分析。
PLoS One. 2014 Nov 12;9(11):e112017. doi: 10.1371/journal.pone.0112017. eCollection 2014.
9
High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting.高发死亡率:低 HIV 流行环境下,因活动性肺结核住院的成年人。
PLoS One. 2014 Mar 18;9(3):e92077. doi: 10.1371/journal.pone.0092077. eCollection 2014.
10
Predictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia.马来西亚结核分枝杆菌/人类免疫缺陷病毒合并感染患者治疗期间死亡的预测因素。
PLoS One. 2013 Aug 12;8(8):e73250. doi: 10.1371/journal.pone.0073250. eCollection 2013.